Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Sees Large Growth in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 299,800 shares, a growth of 1,663.5% from the September 30th total of 17,000 shares. Based on an average daily volume of 420,400 shares, the short-interest ratio is currently 0.7 days.

Ono Pharmaceutical Stock Performance

Shares of OTCMKTS:OPHLY traded down $0.03 during trading on Friday, reaching $4.18. 413,338 shares of the company traded hands, compared to its average volume of 147,536. Ono Pharmaceutical has a 52-week low of $4.10 and a 52-week high of $6.43. The business’s fifty day moving average is $4.57 and its 200-day moving average is $4.69.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.